BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19445983)

  • 1. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
    Gabriel D; Busso N; So A; van den Bergh H; Gurny R; Lange N
    J Control Release; 2009 Sep; 138(3):225-34. PubMed ID: 19445983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.
    Gabriel D; Lange N; Chobaz-Peclat V; Zuluaga MF; Gurny R; van den Bergh H; Busso N
    J Control Release; 2012 Oct; 163(2):178-86. PubMed ID: 22959919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric photosensitizer prodrugs for photodynamic therapy.
    Campo MA; Gabriel D; Kucera P; Gurny R; Lange N
    Photochem Photobiol; 2007; 83(4):958-65. PubMed ID: 17645670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.
    Zuluaga MF; Gabriel D; Lange N
    Mol Pharm; 2012 Jun; 9(6):1570-9. PubMed ID: 22548315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective synovectomy using thrombin-sensitive photodynamic agents.
    Park K
    J Control Release; 2009 Sep; 138(3):224. PubMed ID: 19616048
    [No Abstract]   [Full Text] [Related]  

  • 6. Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.
    Trauner KB; Gandour-Edwards R; Bamberg M; Shortkroff S; Sledge C; Hasan T
    Photochem Photobiol; 1998 Jan; 67(1):133-9. PubMed ID: 9477771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal photodynamic therapy--a treatment option for rheumatic destruction of small joints?
    Funke B; Jungel A; Schastak S; Wiedemeyer K; Emmrich F; Sack U
    Lasers Surg Med; 2006 Oct; 38(9):866-74. PubMed ID: 16977613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients.
    Dietze A; Engesaeter B; Berg K
    Photochem Photobiol Sci; 2005 Apr; 4(4):341-7. PubMed ID: 15803204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic study of ALA-induced endogenous porphyrins in arthritic knee tissues: targeting rheumatoid arthritis PDT.
    Bagdonas S; Kirdaite G; Streckyte G; Graziene V; Leonaviciene L; Bradunaite R; Venalis A; Rotomskis R
    Photochem Photobiol Sci; 2005 Jul; 4(7):497-502. PubMed ID: 15986056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds.
    Gabriel D; Zuluaga MF; Lange N
    Photochem Photobiol Sci; 2011 May; 10(5):689-703. PubMed ID: 21298150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for enhanced photodynamic therapy effects.
    Verma S; Watt GM; Mai Z; Hasan T
    Photochem Photobiol; 2007; 83(5):996-1005. PubMed ID: 17880492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic treatment as a novel approach in the therapy of arthritic joints.
    Hansch A; Frey O; Gajda M; Susanna G; Boettcher J; Bräuer R; Kaiser WA
    Lasers Surg Med; 2008 Apr; 40(4):265-72. PubMed ID: 18412224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
    Gabriel D; Campo MA; Gurny R; Lange N
    Bioconjug Chem; 2007; 18(4):1070-7. PubMed ID: 17477499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
    Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of light emitting diodes in the photodynamic therapy of rheumatoid arthritis.
    Neupane J; Ghimire S; Shakya S; Chaudhary L; Shrivastava VP
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):44-9. PubMed ID: 20230993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations.
    Chowdhary RK; Sharif I; Chansarkar N; Dolphin D; Ratkay L; Delaney S; Meadows H
    J Pharm Pharm Sci; 2003; 6(2):198-204. PubMed ID: 12935430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.
    O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T
    Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.
    Fiehn C; Kratz F; Sass G; Müller-Ladner U; Neumann E
    Ann Rheum Dis; 2008 Aug; 67(8):1188-91. PubMed ID: 18408252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model.
    Bouilloux J; Kiening M; Yapi S; Lange N
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer.
    Suci PA; Varpness Z; Gillitzer E; Douglas T; Young M
    Langmuir; 2007 Nov; 23(24):12280-6. PubMed ID: 17949022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.